Journal of Biopharmaceutical Statistics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.3 | Q2 | 51.5% | 0.680 | Q2 | 72.0% |
| 2024 | 1.2 | Q2 | 53.3% | 0.565 | Q2 | 66.4% |
| 2023 | 1.2 | Q2 | 56.9% | 0.812 | Q2 | 80.2% |
| 2022 | 1.1 | Q3 | 42.5% | 0.721 | Q2 | 77.6% |
| 2021 | 1.5 | Q3 | 60.4% | 0.679 | Q2 | 76.5% |
| 2020 | — | — | 0.557 | Q3 | 69.6% | |
| 2019 | — | — | 0.578 | Q2 | 71.6% | |
| 2018 | — | — | 0.575 | Q2 | 69.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1520-5711
ISSN
1054-3406
region
Northern America
coverage
1991-2026